/Investor DB

Aurum Ventures MKI — Full Portfolio

6 tracked investments · listed companies and verified rows first

Apesterapester.comin𝕏Series A · Jul 2015 · $5M

Apester is a code-free interactive content platform that lets publishers, brands, and creators build experiences such as web stories, videos, and surveys and distribute them across digital media channels to drive engagement, lead generation, and conversions.

AdTechMarketing TechMedia & EntertainmentTel Aviv, IL

Ilan Zamir(CEO & Partner)inOrya Dor(CRO & Partner)inGal Shapira(COO & Partner)in

Co-investorsBrilliance VenturesBlumberg CapitalKreos CapitalMangrove Capital Partners

Nano Dinano-di.comin𝕏Jun 2015 · $11M

Nano Dimension (Nasdaq: NNDM) makes additive manufacturing machines, including Additively Manufactured Electronics (AME) systems for fabricating printed circuit boards in-house and Fabrica micro-AM 3D printers, integrated with factory robotics and deep-learning AI.

Advanced ManufacturingDeep TechHardwareRoboticsNess Ziona

Amit Dror(Executive Officer, Director)inYael Sandler(Executive Officer)inJaim Nulman(Executive Officer)Avi Reichental(Director)Simon Anthony-Fried(Director)Ofir Baharav(Director)

Co-investorsi3 Partners

Nucleixnucleix.comin𝕏Jul 2018

Nucleix is a healthcare company developing diagnostic technology based on DNA/nucleic acid analysis for cancer detection.

BiotechDigital HealthHealthtechMedical Devices

Eli Frydman(President EMEA)

Co-investorsGefen CapitalOrbiMedRA CapitalBlackRockLilly Asia VenturesLYFE Capital+1 more

Scopio Labsscopiolabs.cominSeries C · Feb 2022 · $50M

Scopio Labs develops Full-Field digital cell morphology imaging and AI analysis platforms for hematology laboratories.

Itai Hayut(Co-Founder and CEO)inErez Na'aman(Co-Founder and CTO)in

Co-investorsAescuvestLumir VenturesViola VenturesXB VenturesFORTISSIMO CAPITALOurCrowd

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

KidneyCureSpaceIL

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.